Xu-Nuo Pharma, Inc. acquired the remaining 2% stake in Xynomic Pharmaceuticals Holdings, Inc. (OTCPK:XYNO) on June 17, 2021. As a part of the consideration, Xynomic Pharmaceuticals will receive $4.49 per share as a part of the consideration. Xu-Nuo Pharma owns 98% stake in Xynomic Pharmaceuticals and the transaction is considered as a going private transaction. Post closing of the transaction, Xynomic Pharmaceuticals Holdings will carry out the business as usual. Xu-Nuo Pharma, Inc. completed the acquisition of the remaining 2% stake in Xynomic Pharmaceuticals Holdings, Inc. (OTCPK:XYNO) on June 17, 2021.